Not being a member of the medical/scientific community, I am not privy to the day to day goings on when it comes to learning about the latest advancements in finding a cure for vitiligo, but with the help of the United States Patent and Trademark office, I can get a general picture of current and past works which seem promising for future use.
I had a great time perusing the patents given in hopes of developing the perfect cure…or at least helpful methods of lessening the effects of vitiligo. Okay, some of the information is a little technical and at times a bit difficult to understand, but have a look anyway. You may walk away feeling confident that a cure may be close at hand.
[ad#post-bottom]Vitiligo Patents
• 7435524- Permanent, removable tissue markings
• 7452535- Methods of treatment using CTLA-4 antibodies
• 7452875- Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic
acid compounds, process and intermediate products for their preparation and pharmaceutical
• 7452878- Biaromatic compounds which activate PPAR.gamma. type receptors and
cosmetic/pharmaceutical compositions comprised thereof
• 7452892- Triazolopyrimidine cannabinoid receptor 1 antagonists
• 7456176- Benzotriazine inhibitors of kinases
• 7456288- Heterocyclic compounds and methods of making and using thereof
• 7459531- 50 Human secreted proteins
• 7462486- Methods of selecting T cell receptor V peptides for therapeutic use
• 7462698- Anti-CD26 antibodies and methods of use thereof
• 7465446- Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease
• 7449557- Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
• 7449202- Compositions and methods for prostate and kidney health and disorders, an herbal
• 7438906- Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as
• 7439231- Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
• 7439360- Vanilloid receptor ligands and their use in treatments
• 7439396- Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
• 7442698- Substituted heterocyclic compounds and methods of use
• 7442778- Modified Fc molecules
• 7442807- N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
• 7445779- Methods of modulating IFNy production
• 7446176- 12 human secreted proteins
• 7449184- Fixed dosing of HER antibodies
• 7465466- Compositions and methods for prostate and kidney health and disorders, an herbal
• 7468195- Skin treatment preparation
• 7485647- 2-aminoquinoline derivatives
• 7488717- Methods of inhibiting chemokine binding to chemokine receptors
• 7488749- Therapy of diseases of the eye, the inner ear and the central nervous system
• 7491391- Anti-IL-23 antibodies, compositions, methods and uses
• 7491500- Mammalian cytokine; related reagents
• 7491516- Dual specificity antibodies and methods of making and using
• 7491725- Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
• 7494503- Method and apparatus for acne prevention
• 7494661- Methods for using tetanus toxin for beneficial purposes in animals (mammals)
• 7498027- Methods of treatment using human tumor necrosis factor receptor TR17 antibodies
• 7485315- Compositions comprising a compound of low solubility and a lipophilic amino acid derivative,
uses thereof and process for dissolving a compound of low solubility
• 7485308- 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911,
86216, 25206, and 8843 molecules and uses therefor
• 7483738- Combination stimulating and exothermic heating device and method of use thereof
• 7468449- Phenyl-furan compounds as vitamin D receptor modulators
• 7468457- Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic
• 7470437- Methods of treating conditions with a metal-containing material
• 7470722- Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of
• 7479479- CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and
• 7479484- Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral
• 7482013- Albumin fusion proteins
• 7482147- Ubiquitin protease
• 7482347- Piperazine derivatives with CCR-3 inhibiting activity
• 7482442- HEMCM42 nucleic acids
• 7498298- Monomethylvaline compounds capable of conjugation to ligands
[ad#post-bottom]